Right to Try Act of 2017 [HB-878]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Right to Try Act of 2017 This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are: (1) intended to treat a patient who has been diagnosed with a terminal illness, and (2) authorized by state law. The federal government must allow unrestricted possession and use of such treatments by patients certified by a physician as having exhausted all other treatment options. A manufacturer, distributor, prescriber, dispenser,
(continued...)
HB-878: Right to Try Act of 2017
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On The Constitution And Civil Justice. on 03/02/2017
Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017 [HB-820]
[Healthcare ]
[Public Health ]
[Science ]
[Children and Youth ]
[Funding ]
[Grants ]
Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017 This bill amends the Public Health Service Act to authorize the National Institutes of Health (NIH) to provide support to collect the medical specimens and information of children, adolescents, and young adults with selected cancers that have the least effective treatments in order to achieve a better understanding of these cancers and the effects of treatment. The national childhood cancer registry is reauthorized through FY2022 and revised to authorize
(continued...)
HB-820: Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 02/03/2017
Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 [S.292]
[Healthcare ]
[Public Health ]
[Science ]
[Children and Youth ]
[Funding ]
[Grants ]
[Medicare and Medicaid ]
[Mental Health ]
Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 This bill amends the Public Health Service Act to authorize the National Institutes of Health (NIH) to provide support to collect the medical specimens and information of children, adolescents, and young adults with selected cancers that have the least effective treatments in order to achieve a better understanding of these cancers and the effects of treatment. The national childhood cancer registry is reauthorized through FY2022 and revised to authorize
(continued...)
S.292: Childhood Cancer STAR Act Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018
Sponsored by: Sen. Robert Casey
Became Public Law No: 115-180. on 06/05/2018
Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act [HB-774]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Pharmaceuticals ]
Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act This bill amends title XIX (Medicaid) of the Social Security Act to eliminate restrictions on state Medicaid program coverage of nonprescription drugs for tobacco cessation. Under current law, a state Medicaid program may exclude from coverage, or otherwise restrict, such drugs, except for those recommended to pregnant women.
HB-774: Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act
Sponsored by: Rep. Grace Meng
Referred To The Subcommittee On Health. on 02/03/2017
STOP OD Act of 2017 Stem the Tide of Overdose Prevalence from Opiate Drugs Act of 2017 [HB-664]
[Healthcare ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Public Health ]
[Law Enforcement ]
[National Security ]
[Funding ]
[Grants ]
[Cybersecurity ]
[Technology and Innovation ]
[Data Privacy ]
[Mental Health ]
STOP OD Act of 2017 Stem the Tide of Overdose Prevalence from Opiate Drugs Act of 2017 This bill permits the Centers for Disease Control and Prevention (CDC) to award grants: (1) to expand educational efforts to prevent abuse of opioids, which are drugs with effects similar to opium, such as heroin; (2) to promote treatment of persons who abuse opioids; and (3) to promote understanding of addiction. The Department of Health and Human Services (HHS) may award grants to: (1) support first responders carrying and administering naloxone, which is a
(continued...)
HB-664: STOP OD Act of 2017 Stem the Tide of Overdose Prevalence from Opiate Drugs Act of 2017
Sponsored by: Rep. Barbara Comstock
Referred To The Subcommittee On Emerging Threats And Capabilities. on 02/21/2017
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 [S.204]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to exempt, from specified requirements and restrictions under that Act and other laws, the provision of certain unapproved, investigational drugs to a terminally ill patient who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs. The manufacturer or sponsor of an eligible investigational drug must report annually to the Food and
(continued...)
S.204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Sponsored by: Sen. Chuck Grassley
Became Public Law No: 115-176. on 05/30/2018
Disapproving the action of the District of Columbia Council in approving the Death with Dignity Act of 2016. [HJR-27]
[Healthcare ]
[Public Health ]
Disapproving the action of the District of Columbia Council in approving the Death with Dignity Act of 2016. This joint resolution nullifies the action of the District of Columbia Council in approving the Death with Dignity Act of 2016, signed by the Mayor of the District on December 19, 2016, and transmitted on January 6, 2017, to Congress pursuant to the District of Columbia Home Rule Act. The D.C. Act authorizes terminally ill patients to request and to be prescribed medication to end their lives.
HJR-27: Disapproving the action of the District of Columbia Council in approving the Death with Dignity Act of 2016.
Sponsored by: Rep. Alexander Mooney
Committee Consideration And Mark-up Session Held. Markup Report Cq on 02/13/2017
A joint resolution disapproving the action of the District of Columbia Council in approving the Death with Dignity Act of 2016. [SJR-4]
[Healthcare ]
[Public Health ]
A joint resolution disapproving the action of the District of Columbia Council in approving the Death with Dignity Act of 2016. This joint resolution nullifies the action of the District of Columbia Council in approving the Death with Dignity Act of 2016, signed by the Mayor of the District on December 19, 2016, and transmitted on January 6, 2017, to Congress pursuant to the District of Columbia Home Rule Act. The D.C. Act authorizes terminally ill patients to request and to be prescribed medication to end their lives.
SJR-4: A joint resolution disapproving the action of the District of Columbia Council in approving the Death with Dignity Act of 2016.
Sponsored by: Sen. Mike Lee
Read Twice And Referred To The Committee On Homeland Security And Governmental Affairs. on 01/12/2017
Medical Preparedness Allowable Use Act [HB-437]
[Public Health ]
[Healthcare ]
[Pharmaceuticals ]
[Public Safety ]
[National Security ]
[Funding ]
[Grants ]
[Disaster Relief ]
Medical Preparedness Allowable Use Act (Sec. 2) This bill amends the Homeland Security Act of 2002 to authorize the use of Urban Area Security Initiative and State Homeland Security Grant Program funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities, including the development and maintenance of an initial pharmaceutical stockpile, including medical kits, and diagnostics sufficient to protect first responders, their families, immediate victims, and vulnerable populations from a chemical or biological
(continued...)
HB-437: Medical Preparedness Allowable Use Act
Sponsored by: Rep. Gus Bilirakis
Received In The Senate And Read Twice And Referred To The Committee On Homeland Security And Governmental Affairs. on 02/01/2017
FDA Reauthorization Act of 2017 [HB-2430]
[Pharmaceuticals ]
[Healthcare ]
[Public Health ]
FDA Reauthorization Act of 2017 TITLE I--FEES RELATING TO DRUGS Prescription Drug User Fee Amendments of 2017 (Sec. 102) This bill amends the Federal Food, Drug, and Cosmetic Act to extend through FY2022 and revise Food and Drug Administration (FDA) user fees for brand name drugs. User fees are eliminated for supplemental new drug applications and drug manufacturing facilities. A prescription drug program fee replaces the prescription drug product fee. This annual fee is assessed on a new drug application holder for each approved drug for up to
(continued...)
HB-2430: FDA Reauthorization Act of 2017
Sponsored by: Rep. Frank Pallone
Became Public Law No: 115-52. (txt | Pdf) on 08/18/2017
Opioid Addiction Risk Transparency Act [S.1049]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Overdose Prevention ]
Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
S.1049: Opioid Addiction Risk Transparency Act
Sponsored by: Sen. Margaret Hassan
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/04/2017
Right to Try Act [HB-2368]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Right to Try Act This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are authorized by state law and intended to treat terminally ill patients. Patients receiving these treatments must be certified by a physician as having exhausted all other treatment options and as being at greater risk from their medical condition than the treatment. The physician must explain the treatment to the patient, including that the
(continued...)
HB-2368: Right to Try Act
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On The Constitution And Civil Justice. on 06/07/2017
School-Based Respiratory Health Management Act [HB-2285]
[Healthcare ]
[Public Health ]
[Education ]
[Children and Youth ]
School-Based Respiratory Health Management Act This bill amends the Public Health Service Act to revise the conditions under which the Department of Health and Human Services, in making asthma-related grants, gives preference to a state. A preference is given to states that require elementary and secondary schools to have: (1) on the premises during operating hours at least one individual trained in the administration of rescue medications for allergies and reversible lower airway disorders, and (2) an allergies and reversible lower airway disorders
(continued...)
HB-2285: School-Based Respiratory Health Management Act
Sponsored by: Rep. David Valadao
Referred To The Subcommittee On Health. on 05/05/2017
Sam Farr and Nick Castle Peace Corps Reform Act of 2018 [HB-2259]
[Human Rights ]
[Healthcare ]
[Mental Health ]
[International ]
[Human Services ]
Sam Farr and Nick Castle Peace Corps Reform Act of 2018 This bill increases the monthly pay rate for Peace Corps volunteers. The Peace Corps shall provide initial medical care to a former volunteer for a service-related condition for 180 days after termination of service, which period may be extended under specified circumstances. The bill grants the government jurisdiction over, and imposes penalties upon, persons who commit certain crimes outside of the United States against a volunteer. The Peace Corps Act is amended to authorize the designation
(continued...)
HB-2259: Sam Farr and Nick Castle Peace Corps Reform Act of 2018
Sponsored by: Rep. Ted Poe
Became Public Law No: 115-256. on 10/09/2018
Veteran Overmedication Prevention Act of 2017 [S.992]
[Veterans ]
[Healthcare ]
[Mental Health ]
[Overdose Prevention ]
[Public Health ]
[Pharmaceuticals ]
[Medicare and Medicaid ]
Veteran Overmedication Prevention Act of 2017 This bill requires the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to review the deaths of all covered veterans who died by suicide during the last five years, regardless of whether information relating to such deaths has been reported by the Centers for Disease Control and Prevention. A "covered veteran" is any veteran who received VA hospital care or medical services during the five-year period preceding the veteran's death. The
(continued...)
S.992: Veteran Overmedication Prevention Act of 2017
Sponsored by: Sen. John McCain
Read Twice And Referred To The Committee On Veterans' Affairs. on 05/01/2017
FDA Reauthorization Act of 2017 [S.934]
[Pharmaceuticals ]
[Healthcare ]
[Public Health ]
[Medicare and Medicaid ]
[Funding ]
[Budget and Spending ]
[Consumer Protection ]
FDA Reauthorization Act of 2017 TITLE I--FEES RELATING TO DRUGS Prescription Drug User Fee Amendments of 2017 (Sec. 102) This bill amends the Federal Food, Drug, and Cosmetic Act to extend through FY2022 and revise Food and Drug Administration (FDA) user fees for new drug applications. User fees are eliminated for supplements to new drug applications and drug manufacturing facilities. TITLE II--FEES RELATING TO DEVICES Medical Device User Fee Amendments of 2017 (Sec. 203) The bill extends through FY2022 and revises FDA user fees for medical devices.
(continued...)
S.934: FDA Reauthorization Act of 2017
Sponsored by: Sen. Lamar Alexander
Committee On Health, Education, Labor, And Pensions. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. Markup Report Cq on 05/11/2017
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 [S.870]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Senior Citizens ]
[Pharmaceuticals ]
[Technology and Innovation ]
[Science ]
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to: extend the Independence at Home demonstration program; modify provisions regarding access to home dialysis therapy under Medicare and special needs plans under Medicare Advantage (MA); expand testing of the MA Value-Based Insurance Design test model; allow an MA plan to provide additional telehealth benefits to enrollees and, to chronically ill enrollees, certain supplemental health
(continued...)
S.870: Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Sponsored by: Sen. Robert Casey
Committee On Finance. Reported By Senator Hatch With An Amendment In The Nature Of A Substitute. With Written Report No. 115-146. on 08/03/2017
Restoring the Patient's Voice Act of 2017 [HB-2077]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
[Public Health ]
Restoring the Patient's Voice Act of 2017 This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer. To warrant an exception to the protocol, at least one of the following circumstances must be met: (1) the treatment is contraindicated, (2) the treatment is expected
(continued...)
HB-2077: Restoring the Patient's Voice Act of 2017
Sponsored by: Rep. Sean Maloney
Introduced In House on 04/06/2017
PIMA of 2017 Promoting Integrity in Medicare Act of 2017 [HB-2066]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
PIMA of 2017 Promoting Integrity in Medicare Act of 2017 This bill expands Medicare's prohibition on physician self-referrals to include, with specified exceptions, certain advanced imaging, anatomic pathology, radiation therapy, and physical therapy services. Additionally, the bill establishes increased civil monetary penalties for violations of the self-referral prohibition with respect to those services. The Centers for Medicare & Medicaid Services shall conduct a compliance review with respect to such referrals.
HB-2066: PIMA of 2017 Promoting Integrity in Medicare Act of 2017
Sponsored by: Rep. Dina Titus
Referred To The Subcommittee On Health. on 04/21/2017
Honoring Hometown Heroes Act [HB-1892]
[Defense ]
[Environmental ]
[Finance ]
[Agriculture ]
[Infrastructure ]
[Public Lands and National Parks ]
[Taxes ]
[Trade ]
[Transportation and Motor Vehicles ]
[Budget and Spending ]
[Small Business ]
[Insurance ]
[Disaster Relief ]
[Economic Development ]
[Energy ]
[Food ]
[Healthcare ]
[Housing ]
[Labor, Jobs, Employment ]
[Medicare and Medicaid ]
[Military ]
[Public Health ]
[Education ]
[Veterans ]
[Children and Youth ]
[Family-Related Legislation ]
[Human Services ]
[Pensions ]
[Senior Citizens ]
[Unemployment ]
Honoring Hometown Heroes Act DIVISION A--HONORING HOMETOWN HEROES ACT Honoring Hometown Heroes Act (Sec. 10102) This division authorizes the governor of a state, territory, or possession of the United States or the Mayor of the District of Columbia to proclaim that the U.S. flag shall be flown at half-staff in the event of the death of a first responder (public safety officer) working in such jurisdiction who dies while serving in the line of duty. DIVISION B--SUPPLEMENTAL APPROPRIATIONS, TAX RELIEF, AND MEDICAID CHANGES RELATING TO CERTAIN DISASTERS
(continued...)
HB-1892: Honoring Hometown Heroes Act
Sponsored by: Rep. Ted Poe
Became Public Law No: 115-123. (txt | Pdf) on 02/09/2018